RxDoctor Payments DataLook up a doctor →

Steve Simpson, MD

Family Medicine · Little Rock, ARNPI 1730172958

Payments from drug & device makers

$33,646in general payments, 2019–2025

Across 305 payments — averaging $110.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • IBSA Institut Biochimique SA$16K
  • Novo Nordisk AS$9K
  • Paratek Pharmaceuticals, Inc.$5K
  • AbbVie$1K
  • Pfizer$363
  • Amgen$307
  • plus $2K from 42 others

What the payments were for

  • Food & beverage$4,184100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$33,646 in reported general payments places this provider in the 95th percentile of 1,347 family medicine providers in Arkansas.

See all family medicine providers in Arkansas

Medicare billing

Part B allowed, 2024
$90,805
Medicare patients
357
Services billed
4,504

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide72$69,526
MounjaroTirzepatide48$48,166
JanuviaSitagliptin Phosphate35$33,689
JardianceEmpagliflozin40$32,640
EliquisApixaban31$25,650
Trelegy ElliptaFluticasone/Umeclidin/Vilanter24$23,630
TradjentaLinagliptin17$11,503
LinzessLinaclotide12$10,785
MyrbetriqMirabegron14$10,038
FarxigaDapagliflozin Propanediol11$8,480
Breo ElliptaFluticasone/Vilanterol19$7,555
Arnuity ElliptaFluticasone Furoate22$6,766
Atorvastatin Calcium593$4,924
Omeprazole394$4,571
Metoprolol Succinate339$4,560

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$94$69,52672 claims
Lilly USA, LLCMounjaro$168$48,16648 claims
Boehringer IngelheimJardiance, Tradjenta$94$44,14257 claims
GSKTrelegy Ellipta, Breo Ellipta, Arnuity Ellipta$248$37,95265 claims
MerckJanuvia$256$33,68935 claims
PfizerEliquis$363$25,65031 claims
AbbVieLinzess, Synthroid$1,042$14,46777 claims
Astellas Pharma US IncMyrbetriq$82$10,03814 claims
AstraZenecaFarxiga$131$8,48011 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,347 family medicine providers in Arkansas.

Other family medicine in Little Rock

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →